Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
ZYMOGENETICS, INC.;INTELLECTUAL PROPERTY DEPARTMENT
SEATTLE, WA US
1. 20110039268 CYTOKINE PROTEIN FAMILY - polynucleotide and polypeptide molecules for zcyto20 zcyto21 zcyto22 02-17-20112. 20110027263 SOLUBLE INTERLEUKIN-20 RECEPTOR - soluble receptor to IL-20 having two polypeptide subunits, IL-20RA and IL-20RB 02-03-2011
3. 20110008820 METHODS OF DETERMINING DOSE OF IL-31 AGONIST TO TREAT PULMONARY INFLAMMATION 01-13-2011
4. 20110008280 METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS 01-13-2011
5. 20110003973 ANTIBODIES TO ZALPHA11 CYTOKINE RECEPTORS 01-06-2011
6. 20110002882 METHODS OF TREATING CANCER USING IL-21 - Methods for treating mammals with cancer using molecules that have an IL-21 functional activity are described 01-06-2011
7. 20100322898 METHODS OF TREATING CANCER USING IL-21 - Methods for treating mammals with cancer using molecules that have an IL-21 functional activity are described 12-23-2010
8. 20100316646 COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES 12-16-2010
9. 20100316600 METHODS OF TREATING CANCER USING IL-21 - Methods for treating mammals with cancer using molecules that have an IL-21 functional activity are described 12-16-2010
10. 20100316599 METHODS OF TREATING CANCER USING IL-21 - Methods for treating mammals with cancer using molecules that have an IL-21 functional activity are described 12-16-2010
11. 20100316598 METHODS OF TREATING CANCER USING IL-21 - Methods for treating mammals with cancer using molecules that have an IL-21 functional activity are described 12-16-2010
12. 20100316597 METHODS OF TREATING CANCER USING IL-21 - Methods for treating mammals with cancer using molecules that have an IL-21 functional activity are described 12-16-2010
13. 20100311120 HUMAN CYTOKINE RECEPTOR - Cytokines and their receptors have proven usefulness in both basic research and as therapeutics 12-09-2010
14. 20100310565 ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F AND METHODS OF USING THE SAME 12-09-2010
15. 20100310533 METHODS OF USING IL-21 FOR ADOPTIVE IMMUNOTHERAPY AND IDENTIFICATION OF TUMOR ANTIGENS 12-09-2010
16. 20100310505 METHODS OF TREATING CANCER USING IL-21 - Methods for treating mammals with cancer using molecules that have an IL-21 functional activity are described 12-09-2010
17. 20100298543 MAMMALIAN ZCYTOR 11 - Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed 11-25-2010
18. 20100298230 USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS 11-25-2010
19. 20100297701 TRIMERIZING POLYPEPTIDES - method of preparing a trimeric protein comprising culturing a host cell transformed or transfected with an expression vector 11-25-2010
20. 20100297125 METHODS OF TREATING PAIN USING ANTAGONISTS OF IL-31, IL-31RA AND/OR OSMRB 11-25-2010
21. 20100297068 METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 11-25-2010
22. 20100297065 HOMOGENEOUS PREPARATIONS OF IL-31 - Homogeneous preparations of human and murine IL-31 have been produced by mutating one or more of the cysteine 11-25-2010
23. 20100297064 CYTOKINE ZALPHA11 LIGAND ANTIBODIES - Antibodies that bind to polypeptides and peptides comprising the sequence of zalpha11 Ligand as shown in SEQ ID 11-25-2010
24. 20100297063 CYTOKINE ZALPHA11 LIGAND ANTIBODIES - Antibodies that bind to polypeptides and peptides comprising the sequence of zalpha11 Ligand as shown in SEQ ID 11-25-2010
25. 20100292151 USE OF HUMAN CYTOKINE RECEPTOR - Cytokines and their receptors have proven usefulness in both basic research and as therapeutics 11-18-2010
26. 20100291030 USE OF IL-28 AND IL-29 TO TREAT CANCER AND AUTOIMMUNE DISORDERS 11-18-2010
27. 20100291029 METHODS OF USING IL-21 - allelic variation in the IL-21 receptor can result in reduced IFN 11-18-2010
28. 20100266600 METHODS OF USING IL-31 ANTAGONISTS IN DISEASES MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE T CELLS 10-21-2010
29. 20100266597 CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS - Novel polypeptide combinations polynucleotides encoding the polypeptides and related compositions and methods are 10-21-2010
30. 20100266499 CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS - Novel polypeptide combinations polynucleotides encoding the polypeptides and related compositions and methods are 10-21-2010
31. 20100227813 A METHOD OF USING INTERFERON-LIKE POTEIN ZCYTO20 (IL-28A) OR ZCYTO22(IL-28B) TO TREAT HEPATITIS B 09-09-2010
32. 20100222557 CYTOKINE ZALPHA11LIGAND ANTIBODIES - Antibodies that bind to polypeptides and peptides comprising the sequence of zalpha11 Ligand as shown in SEQ ID NO: 09-02-2010
33. 20100222556 ANTIBODIES TO CYTOKINE RECEPTOR ZALPHA11 09-02-2010
34. 20100222552 PRODUCTION AND PURIFICATION OF IL-29 - The expression vectors and methods using an E 09-02-2010
35. 20100222266 A METHOD OF USING INTERFERON-LIKE PROTEIN ZCYTO21(IL-29) TO TREAT HEPATITIS B 09-02-2010
36. 20100221244 ANTAGONIZING SIGNAL TRANSDUCTION IN DORSAL ROOT GANGLION CELLS IN A SUBJECT WITH IL-31 ANTAGONISTS 09-02-2010
37. 20100210825 ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION 08-19-2010
38. 20100197895 ANTIBODIES TO HUMAN TUMOR NECROSIS FACTOR RECEPTOR 08-05-2010
39. 20100197575 SOLUBLE INTERLEUKIN-20 RECEPTOR - soluble receptor to IL-20 having two polypeptide subunits, IL-20RA and IL-20RB 08-05-2010
40. 20100104531 HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29 04-29-2010
41. 20100099184 POLYNUCLEOTIDES ENCODING CLASS II CYTOKINE RECEPTOR-7 04-22-2010
42. 20100075377 TETRAMERIZING POLYPEPTIDES AND METHODS OF USE 03-25-2010
43. 20100074905 METHODS FOR SOLUBLE ZALPHA11 CYTOKINE RECEPTORS 03-25-2010
44. 20100055101 CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS - Novel polypeptide combinations polynucleotides encoding the polypeptides and related compositions and methods are 03-04-2010
45. 20100041873 ANTI-HUMAN IL-21 MONOCLONAL ANTIBODIES - Human anti-human IL-21 monoclonal antibodies and the hybridomas that produce them are presented 02-18-2010
46. 20100008917 TREATMENT OF APLASTIC ANEMIA - Methods of treating aplastic anemia in a patient and of increasing blood cell production in a patient having aplastic 01-14-2010
47. 20100008915 METHODS FOR TREATING DISEASE USING AN ANTI-IL-21 RECEPTOR ANTIBODY 01-14-2010
48. 20100008909 VARIABLE REGION SEQUENCES OF IL-31 MONOCLONAL ANTIBODIES AND METHODS OF USE 01-14-2010
49. 20100003722 PRODUCTION AND PURIFICATION OF IL-29 - The expression vectors and methods using an E 01-07-2010
50. 20090326204 INTERFERON-LIKE PROTEIN ZCYTO21 - polynucleotide and polypeptide molecules for Zcyto21 an interferon-like protein 12-31-2009
51. 20090311750 METHODS OF CONVERTING FAB SEQUENCES INTO SINGLE CHAIN ANTIBODY SEQUENCES 12-17-2009
52. 20090285778 USE OF INTERLEUKIN-19 TO TREAT CERVICAL CANCER 11-19-2009
53. 20090280121 METHODS OF TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLS 11-12-2009
54. 20090274700 IL-31 RECEPTOR ANTIBODIES - Novel polypeptides polynucleotides encoding the polypeptides and related compositions and methods are disclosed for zcytor17 11-05-2009
55. 20090274694 CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS - Novel polypeptide combinations polynucleotides encoding the polypeptides and related compositions and methods are 11-05-2009
56. 20090269304 METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY 10-29-2009
57. 20090263352 METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS 10-22-2009
58. 20090252732 VARIABLE REGION SEQUENCES OF IL-31 MONOCLONAL ANTIBODIES AND METHODS OF USE 10-08-2009
59. 20090252730 METHODS OF TREATING SKIN DISORDERS USING AN IL-31RA ANTAGONIST 10-08-2009
60. 20090221802 SOLUBLE ZALPHA11 CYTOKINE RECEPTORS - Novel polypeptide combinations polynucleotides encoding the polypeptides and related compositions and methods are 09-03-2009
61. 20090220519 ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION 09-03-2009
62. 20090220502 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS 09-03-2009
63. 20090220417 METHODS OF USING IL-31 MONOCLONAL ANTIBODIES TO REDUCE INFLAMMATION 09-03-2009
64. 20090208494 HUMANIZED ANTIBODY MOLECULES SPECIFIC FOR IL-31 08-20-2009
65. 20090203541 MSP AND ITS DOMAINS AS FRAMEWORKS FOR NOVEL BINDING MOLECULES 08-13-2009
66. 20090202534 COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES 08-13-2009
67. 20090202477 METHODS OF TREATING INFECTIONS USING IL-21 08-13-2009
68. 20090196882 METHODS OF PRODUCING ANTIBODIES TO ZALPHA11 CYTOKINE RECEPTORS 08-06-2009
69. 20090192292 MURINE ZCYTOR17 LIGAND POLYPEPTIDES AND POLYNUCLEOTIDES 07-30-2009
70. 20090192291 PRODUCTION OF HOMOTRIMERIC FUSION PROTEINS 07-30-2009
71. 20090191214 ANTI-HUMAN IL-21 MONOCLONAL ANTIBODIES - Human anti-human IL-21 monoclonal antibodies and the hybridomas that produce them are presented 07-30-2009
72. 20090191150 METHODS OF TREATING INFECTIONS USING IL-21 07-30-2009
73. 20090186030 ANTIBODIES THAT BIND BOTH BCMA AND TACI - Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand such as a 07-23-2009
74. 20090175876 METHODS OF USING PHHLA2 TO CO-STIMULATE T-CELLS 07-09-2009
75. 20090156795 ZSIG33-LIKE POLYNUCLEOTIDES - polynucleotide related to the zsig33 peptide, including agonists, antagonists, and antibodies 06-18-2009
76. 20090156495 COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES 06-18-2009
77. 20090155281 METHODS OF USING ANTIBODIES THAT BIND BOTH BCMA AND TACI 06-18-2009
78. 20090149636 CYTOKINE PROTEIN FAMILY - polynucleotide and polypeptide molecules for zcyto20 zcyto21 zcyto22 06-11-2009
79. 20090149635 ANTIBODIES TO HUMAN ZCYTOR17 LIGAND - zcytor17lig polynucleotide, polypeptide and anti-zcytor17 antibody molecules 06-11-2009
80. 20090092999 METHODS OF PREDICTING THERAPEUTIC RESPONSE IN ATOPIC DERMATITIS TO IL-31 ANTAGONISTS 04-09-2009
81. 20090092611 ANTIBODIES THAT BIND BOTH BCMA AND TACI - Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand such as a 04-09-2009
82. 20090092545 ANTIBODIES THAT BIND BOTH BCMA AND TACI - Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand such as a 04-09-2009
83. 20090087404 METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY 04-02-2009
84. 20090081168 METHOD OF FORMING A PEPTIDE-RECEPTOR COMPLEX WITH ZSIG33 03-26-2009
85. 20090075341 IL-21 ANTAGONISTS - Monoclonal antibodies are identified that bind the IL-21 protein 03-19-2009
86. 20090075338 DIMERIC FUSION PROTEINS AND MATERIALS AND METHODS FOR PRODUCING THEM 03-19-2009
87. 20090074799 ANTIBODIES TO CLASS II CYTOKINE RECEPTOR-7 03-19-2009
88. 20090074661 ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION 03-19-2009
89. 20090069274 INTERFERON-LIKE PROTEIN ZCYTO21 - polynucleotide and polypeptide molecules for Zcyto21 an interferon-like protein 03-12-2009
90. 20090030186 PICHIA METHANOLICA SECRETORY SIGNAL - Novel Pichia methanolica secretory signal polypeptides polynucleotides encoding the polypeptides 01-29-2009
91. 20090028865 METHOD OF TREATING HEPATOCELLULAR CARCINOMA 01-29-2009
92. 20090022723 ANTI-IL-TIF ANTIBODIES AND METHODS OF USING IN INFLAMMATION 01-22-2009
93. 20090018080 METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS 01-15-2009
94. 20090004199 ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F AND METHODS OF USING THE SAME 01-01-2009
95. 20080311104 STABILIZED THROMBIN COMPOSITIONS - , processes for preparing them, and kits comprising them are disclosed 12-18-2008
96. 20080299129 ANTAGONISTS TO IL-17A, IL-17F, AND IL-23P19 AND METHODS OF USE 12-04-2008
97. 20080293122 Method for Activating Prethrombin-1 - Methods for converting prethrombin-1 to thrombin are disclosed 11-27-2008
98. 20080279816 HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29 11-13-2008
99. 20080260738 SINGLE CHAIN FC, METHODS OF MAKING AND METHODS OF TREATMENT 10-23-2008
100. 20080260737 COMBINATION OF BLyS AND/OR APRIL INHIBITION AND IMMUNNOSUPPRESSANTS FOR TREATMENT OF AUTOIMMUNE DISEASE 10-23-2008
101. 20080260686 METHODS OF USING IL-31 TO TREAT AIRWAY HYPER-RESPONSIVENESS AND ASTHMA 10-23-2008
102. 20080247945 ANTI-IL-20 ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION 10-09-2008
103. 20080242839 HUMAN CYTOKINE RECEPTOR - Cytokines and their receptors have proven usefulness in both basic research and as therapeutics 10-02-2008
104. 20080241138 SOLUBLE IL-17RA/RC FUSION PROTEINS AND RELATED METHODS 10-02-2008
105. 20080233115 ANTI-IL-20 ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION 09-25-2008
106. 20080233114 NOVEL FGF HOMOLOGS - polynucleotide and polypeptide molecules for zFGF5 a novel member of the FGF family 09-25-2008
107. 20080220478 TRIMERIZING POLYPEPTIDES - method of preparing a trimeric protein comprising culturing a host cell transformed or transfected with an expression vector 09-11-2008
108. 20080219985 PROK2 ANTAGONISTS AND METHODS OF USE - methods of using PROK2 and PROK1 antagonist including monoclonal antibodies to treat inflammation 09-11-2008
109. 20080219978 Soluble FcgammaRIA and related methods - Disclosed are soluble Fc 09-11-2008
110. 20080214788 INTERFERON-LIKE PROTEIN ZCYTO21 - polynucleotide and polypeptide molecules for Zcyto21 an interferon-like protein 09-04-2008
111. 20080214785 HUMAN CYTOKINE RECEPTOR - Cytokines and their receptors have proven usefulness in both basic research and as therapeutics 09-04-2008
112. 20080213831 HUMAN CYTOKINE RECEPTOR - Cytokines and their receptors have proven usefulness in both basic research and as therapeutics 09-04-2008
113. 20080207886 MAMMALIAN CYTOKINE-LIKE POLYPEPTIDE-10 - mammalian cytokine-like polypeptide called Mammalian Cytokine-like polypeptide-10 08-28-2008